Related Experiment Videos
Antimicrobial activity of Obioactin.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology
|March 1, 1984
Summary
Obioactin, a novel bovine serum preparation, showed efficacy against Trypanosoma cruzi infections when combined with nifurtimox. However, it demonstrated enhanced bacterial digestion in macrophages and potential antiviral activity in vitro.
Area of Science:
- Immunology
- Parasitology
- Microbiology
Background:
- A novel enzyme-hydrolyzed toxoplasma-hyperimmune bovine serum preparation, Obioactin, was developed.
- Its antimicrobial and related actions against various pathogens were investigated.
Purpose of the Study:
- To evaluate the efficacy of Obioactin against protozoa, bacteria, and viruses in vivo and in vitro.
- To assess the combination therapy of Obioactin with nifurtimox (Lampit) for experimental infections.
Main Methods:
- In vivo studies using experimental Trypanosoma cruzi infections in mice.
- In vitro assays assessing bacterial digestion in macrophages.
- In vitro evaluation of antiviral activity.
Main Results:
- Obioactin showed appreciable efficacy in combination with nifurtimox against Trypanosoma cruzi in mice.
- Prophylactic use of Obioactin alone or with nifurtimox was ineffective in mice.
- In vitro, Obioactin significantly accelerated bacterial digestion in mouse peritoneal macrophages (3-10 times stronger).
- An inhibitory effect on in vitro viral infectivity was suggested.
Conclusions:
- Obioactin demonstrates potential as an antimicrobial agent, particularly in combination therapy for certain protozoal infections.
- Its ability to enhance macrophage-mediated bacterial clearance and inhibit viral infectivity warrants further investigation.